AlphaStocks

ADUS vs MD

As of Sep 20, 2026, Addus HomeCare (ADUS) scores 5.0/10 and Pediatrix Medical Group (MD) 6.9/10 on AlphaStocks' five-model composite, so MD scores higher. ADUS trades 13% below its model fair value; MD trades 25% below its model fair value.

ADUS

Addus HomeCare Corp

5.0

Consider Buy

$117.03

MD

Pediatrix Medical Group, Inc.

6.9

Consider Buy

$25.93

ADUS vs MD: Which is the Better Investment?

Addus HomeCare Corp (ADUS) scores 5.0/10 while Pediatrix Medical Group, Inc. (MD) scores 6.9/10 on AlphaStocks' composite model. Pediatrix Medical Group, Inc. has the higher composite rating of Consider Buy. On a P/E basis, Pediatrix Medical Group, Inc. trades at 13.4x, making it the more attractively priced of the two. Pediatrix Medical Group, Inc. trades further below its estimated fair value.

This comparison is algorithmically generated and is not financial advice.

MetricADUSMD
Scores & Fundamentals
Composite Score5.0/106.9/10
RatingConsider BuyConsider Buy
Price$117.03$25.93
P/E Ratio22.413.4
ROE9.0%18.8%
Market Cap$2B$2B
Fair Value$134.43$34.74
Dividend Yield
Sector Rank#107 of 168#17 of 168
Model Verdicts
PiotroskiStrongAttractive
BuffettNeutralAttractive
GrahamCautionCaution
LynchAttractiveNeutral
GreenblattLimited DataStrong
View full ADUSanalysis →View full MDanalysis →

Related comparisons

Compare any two stocks →

ADUS vs MD: Which Stock Scores Higher?

Addus HomeCare Corp (ADUS) and Pediatrix Medical Group, Inc. (MD) are both in the Health Care sector. MD currently leads with a composite score of 6.9/10 (Consider Buy) compared to ADUS's 5.0/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer